Mark N. Jabbour

907 total citations
36 papers, 670 citations indexed

About

Mark N. Jabbour is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark N. Jabbour has authored 36 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark N. Jabbour's work include Sarcoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Viral-associated cancers and disorders (3 papers). Mark N. Jabbour is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Viral-associated cancers and disorders (3 papers). Mark N. Jabbour collaborates with scholars based in Lebanon, United States and France. Mark N. Jabbour's co-authors include Fouad Boulos, Florence M. Hofman, Ghazi Zaatari, Ayman Tawil, Rihab Nasr, Charles Y. Liu, Steven L. Giannotta, Ali Bazarbachi, Christian G. Samuelson and J. Bradley Elder and has published in prestigious journals such as Blood, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Mark N. Jabbour

36 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark N. Jabbour Lebanon 18 230 164 135 102 90 36 670
Maria Melachrinou Greece 17 231 1.0× 166 1.0× 93 0.7× 131 1.3× 123 1.4× 54 722
Joya Pawade United Kingdom 16 290 1.3× 148 0.9× 73 0.5× 121 1.2× 119 1.3× 43 749
Ramapriya Ganti United States 11 270 1.2× 179 1.1× 138 1.0× 141 1.4× 75 0.8× 15 600
Yixiong Liu China 13 252 1.1× 157 1.0× 123 0.9× 85 0.8× 80 0.9× 38 547
Howard R. Higley United States 12 220 1.0× 170 1.0× 62 0.5× 62 0.6× 82 0.9× 19 939
Masafumi Toyoshima Japan 18 494 2.1× 231 1.4× 145 1.1× 152 1.5× 117 1.3× 61 1.1k
Jun Fu China 17 392 1.7× 136 0.8× 291 2.2× 99 1.0× 127 1.4× 44 767
M. Bianchi Italy 12 330 1.4× 191 1.2× 105 0.8× 115 1.1× 110 1.2× 43 704
María Dirlei Begnami Brazil 19 390 1.7× 323 2.0× 158 1.2× 216 2.1× 172 1.9× 51 961
Shinichi Komiyama Japan 16 189 0.8× 213 1.3× 79 0.6× 133 1.3× 238 2.6× 76 882

Countries citing papers authored by Mark N. Jabbour

Since Specialization
Citations

This map shows the geographic impact of Mark N. Jabbour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Jabbour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Jabbour more than expected).

Fields of papers citing papers by Mark N. Jabbour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark N. Jabbour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Jabbour. The network helps show where Mark N. Jabbour may publish in the future.

Co-authorship network of co-authors of Mark N. Jabbour

This figure shows the co-authorship network connecting the top 25 collaborators of Mark N. Jabbour. A scholar is included among the top collaborators of Mark N. Jabbour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark N. Jabbour. Mark N. Jabbour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahait, Mohammed, Deborah Mukherji, Mark N. Jabbour, et al.. (2017). Second primary malignancy after radical prostatectomy in a cohort from the Middle East. Prostate International. 6(2). 46–49. 2 indexed citations
2.
Nassar, Farah, Rabih Talhouk, Nathalie K. Zgheib, et al.. (2017). microRNA Expression in Ethnic Specific Early Stage Breast Cancer: an Integration and Comparative Analysis. Scientific Reports. 7(1). 16829–16829. 29 indexed citations
3.
Hammoud, Rola, Mark N. Jabbour, Ayman Tawil, Hala Ghattas, & Omar Obeid. (2017). Phosphorus Supplementation Mitigated Food Intake and Growth of Rats Fed a Low-Protein Diet. Current Developments in Nutrition. 1(8). e000943–e000943. 8 indexed citations
4.
Mukherji, Deborah, Mark N. Jabbour, Sally Temraz, et al.. (2015). Programmed Death-Ligand 1 Expression in Muscle-Invasive Bladder Cancer Cystectomy Specimens and Lymph Node Metastasis: A Reliable Treatment Selection Biomarker?. Clinical Genitourinary Cancer. 14(2). 183–187. 40 indexed citations
5.
Nawaz, Zafar, Sandra E. Ghayad, Mark N. Jabbour, et al.. (2015). p53 Restoration in Induction and Maintenance of Senescence: Differential Effects in Premalignant and Malignant Tumor Cells. Molecular and Cellular Biology. 36(3). 438–451. 19 indexed citations
6.
7.
Makoukji, Joelle, Mohamad Raad, Nadine J. Makhoul, et al.. (2015). Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer Patients. Frontiers in Oncology. 5. 215–215. 13 indexed citations
8.
Jabbour, Mark N., Muhieddine Seoud, Hikmat Al‐Ahmadie, Fadi W. Abdul‐Karim, & Ghazi Zaatari. (2014). ASPL-TFE3 Translocation in Vulvovaginal Alveolar Soft Part Sarcoma. International Journal of Gynecological Pathology. 33(3). 263–267. 7 indexed citations
9.
Hajj, Hiba El, Bariaa Khalil, Rihab Nasr, et al.. (2014). Preclinical efficacy of the synthetic retinoid ST1926 for treating adult T-cell leukemia/lymphoma. Blood. 124(13). 2072–2080. 34 indexed citations
10.
Saleh, Ramy, et al.. (2014). Myofibroma of the tongue: A case report of a rapidly growing tumor and review of characteristics. Journal of Oral and Maxillofacial Surgery Medicine and Pathology. 27(3). 422–426. 2 indexed citations
11.
Barada, Kassem, Robert Habib, Ahmad Malli, et al.. (2014). Prediction of celiac disease at endoscopy. Endoscopy. 46(2). 110–119. 31 indexed citations
12.
Mahfouz, Rami, Fadi Farhat, Arafat Tfayli, et al.. (2014). Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: A retrospective study of the Lebanese population. Oncology Reports. 32(5). 2223–2229. 16 indexed citations
13.
Maakaron, Joseph, et al.. (2013). A liver mass in an iron‐overloaded thalassaemia intermedia patient. British Journal of Haematology. 161(1). 1–1. 8 indexed citations
14.
Charafeddine, Khalil M., et al.. (2012). Extended Use of Serum Free Light Chain as a Biomarker in Lymphoproliferative Disorders. American Journal of Clinical Pathology. 137(6). 890–897. 23 indexed citations
15.
Jabbour, Mark N., et al.. (2011). Follicular Dendritic Cell Sarcoma of the Head and Neck Expressing Thyroid Transcription Factor-1. Applied immunohistochemistry & molecular morphology. 22(9). 705–712. 12 indexed citations
16.
Otrock, Zaher K., et al.. (2010). Myasthenia gravis developing in a patient with CNS lymphoma. International Journal of Hematology. 91(3). 522–524. 7 indexed citations
17.
Jabbour, Mark N.. (2009). Chromatid recommensuration after segmental duplication. Theoretical Biology and Medical Modelling. 6(1). 1–4. 23 indexed citations
18.
Kardosh, Adel, Peter Pyrko, Yen‐Ting Liu, et al.. (2007). Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib. Journal of Biomedical Science. 14(5). 647–662. 14 indexed citations
19.
Kardosh, Adel, Mark N. Jabbour, Ligaya Pen, et al.. (2007). Glioma-associated endothelial cells show evidence of replicative senescence. Experimental Cell Research. 313(6). 1192–1202. 21 indexed citations
20.
Doyon, D, et al.. (1988). [Magnetic resonance and salivary pathology. Identification of a lipoma of the parotid gland].. PubMed. 89(2). 117–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Melachrinou Breakdown of academic impact, for papers by Joya Pawade Breakdown of academic impact, for papers by Ramapriya Ganti Breakdown of academic impact, for papers by Yixiong Liu Breakdown of academic impact, for papers by Howard R. Higley Breakdown of academic impact, for papers by Masafumi Toyoshima Breakdown of academic impact, for papers by Jun Fu Breakdown of academic impact, for papers by M. Bianchi Breakdown of academic impact, for papers by María Dirlei Begnami Breakdown of academic impact, for papers by Shinichi Komiyama
Rankless by CCL
2026